Search
Kamada Ltd
KMDAAdd to Watchlist
6.940USD
-0.050-0.72%
Market hours （ET）Quotes delayed by 15 min
400.34MMarket Cap
19.81P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-27The current earnings forecast score of Kamada Ltd is 8.67, ranking 12 out of 155 in the Pharmaceuticals industry. The average price target is 13.00, with a high of 15.00 and a low of 11.00.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
13.000
Target Price
+84.14%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Kamada Ltd
KMDA
3
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
34
Pfizer Inc
PFE
32
AbbVie Inc
ABBV
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Kamada Ltd's expected revenue for the next quarter?
Kamada Ltd's expected revenue is 50.66M.
What is Kamada Ltd's price target?
Analysts forecast that Kamada Ltd's price target is USD 13.00, with the highest forecast at USD 15.00 and the lowest forecast at USD 11.00.
How have Kamada LtdKMDA's recent earnings per share performed?
The market expectation was USD 0.07, while Kamada LtdKMDA's earnings per share (EPS) for the previous quarter was USD 0.06. EPS for the next quarter is expected at USD 0.11.
What is the analyst rating for Kamada Ltd?
Based on the ratings of Kamada Ltd's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.